Abilify
NDC Package 55154-2021-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Abilify is aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). Marketed by Cardinal Health, this product is identified by NDC 55154-2021 and is authorized under FDA application NDA021436.

Identification & Billing

NDC Package Code
55154-2021-7
Package Description
14 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
55154202107

Clinical Specifications

Proprietary Name
Abilify
Dosage Form
-
Usage Information
Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

Regulatory & Marketing

Labeler Name
Cardinal Health
FDA Application #
NDA021436
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-15-2002
End Marketing Date
08-31-2017
Listing Expiration
08-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55154-2021). Click a package code to view its specific billing and regulatory data.

10 BLISTER PACK in 1 BAG / 1 TABLET in 1 BLISTER PACK
1140 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-2021-7 identifies a specific commercial package of 14 tablet in 1 blister pack of Abilify, labeled by Cardinal Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cardinal Health on November 15, 2002. The current certification is valid through August 31, 2017.

What are the primary indications for this medication?

Aripiprazole is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). It may also be used in combination with other medication to treat depression. Aripiprazole is known as an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals in the brain (neurotransmitters). This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur.

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154202107. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-2021-7
11-Digit CMS (5-4-2)
55154-2021-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.